2008•Chinese Journal of New Drugs and Clinical RemediesRequires access

Bioequivalence of memantine capsules and tablets in human volunteers

Xiaohong Chen

Open publisher page 0 citations

Abstract

AIM To evaluate the bioequivalenee of memantine tablets and capsules.METHODS A randomized,cross over designed trial was conducted in 20 healthy volunteers.The plasma concentrations of memantine were determined by HPLC-MS after a single oral dose of 10 mg tablets of the test and reference preparation,and the pharmacokinetics parameters of memantine were obtained using DAS 2.0 software. RESULTS The pharmacokinetic parameters of the capsule vs tablet drug were as follows:t_(max)(6.1±s 2.4)h and(6.6±2.6)h,c_(max)(13±3)μg·L~(-1)and(12±4)μg·L~(-1),t_(1/2)(63±14)h and(64±12)h,AUC_(0-1) (902±292)μg·h·L~(-1) and (845±256)μg·h·L~(-1).The relative bioavailability of memantine capsules was(110±28)%.The result of statistical analysis showed that there was no significant difference between c_(max),AUC_(0-1) and t_(max) of the two preparations.CONCLUSION The memantine capsules and tablets were bioequivalent.

About this research paper

What this paper is about

AIM To evaluate the bioequivalenee of memantine tablets and capsules.METHODS A randomized,cross over designed trial was conducted in 20 healthy volunteers.The plasma concentrations of memantine were determined by HPLC-MS after a single oral dose of 10 mg tablets of the test and reference preparation,and the pharmacokinetics parameters of memantine were obtained using DAS 2.0 software. RESULTS The pharmacokinetic parameters of the capsule vs tablet drug were as follows:t_(max)(6.1±s 2.4)h and(6.6±2.6)h,c_(max)(13±3)μg·L~(-1)and(12±4)μg·L~(-1),t_(1/2)(63±14)h and(64±12)h,AUC_(0-1) (902±292)μg·h·L~(-1) and (845±256)μg·h·L~(-1).The relative bioavailability of memantine capsules was(110±28)%.The result of statistical analysis showed that there was no significant difference between c_(max),AUC_(0-1) and t_(max) of the two preparations.CONCLUSION The memantine capsules and tablets were bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM To evaluate the bioequivalenee of memantine tablets and capsules.METHODS A randomized,cross over designed trial was conducted in 20 healthy volunteers.The plasma concentrations of memantine were determined by HPLC-MS after a single oral dose of 10 mg tablets of the test and reference preparation,and the pharmacokinetics parameters of memantine were obtained using DAS 2.0 software. RESULTS The pharmacokinetic parameters of the capsule vs tablet drug were as follows:t_(max)(6.1±s 2.4)h and(6.6±2.6)h,c_(max)(13±3)μg·L~(-1)and(12±4)μg·L~(-1),t_(1/2)(63±14)h and(64±12)h,AUC_(0-1) (902±292)μg·h·L~(-1) and (845±256)μg·h·L~(-1).The relative bioavailability of memantine capsules was(110±28)%.The result of statistical analysis showed that there was no significant difference between c_(max),AUC_(0-1) and t_(max) of the two preparations.CONCLUSION The memantine capsules and tablets were bioequivalent.

Key concepts: Bioequivalence, Memantine, Pharmacokinetics, Bioavailability, Pharmacology, Crossover study, Plasma concentration, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Bioequivalence of memantine capsules and tablets in human volunteers — Research Paper | ScholarLens